Ignite Creation Date:
2025-12-25 @ 2:13 AM
Ignite Modification Date:
2026-05-13 @ 8:28 PM
Study NCT ID:
NCT00581360
Status:
COMPLETED
Last Update Posted:
2016-11-07
First Post:
2007-12-19
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Phase II Trial of Doxorubicin and Bortezomib in Patients With Incurable Adenoid Cystic Carcinoma of the Head and Neck
Sponsor:
University of Pittsburgh
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
06-124
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | INDUSTRY | View |